Clinical trials for breast cancer
80 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Breast cancer
#NCT05800275
HER2 Positive
Metastatic
1
2
3 or more
Centre François Baclesse (Caen ), Institut Godinot (Reims), Centre Jean Perrin (Clermont Ferrand ), Centre Léon Bérard (Lyon), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ) (and 5 more...)
UNICANCER
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
#NCT05732831
Locally Advanced
Metastatic
Metastatic Castration-resistant
MTAP
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Tango Therapeutics
Phase 2
Breast cancer
#NCT05625087
HER2 Negative
HR Positive
Metastatic
PIK3CA
1
Hormone therapy
Systemic Treatment-Naive
Centre Hospitalier de la Côte Basque (Bayonne), CHU Amiens-Picardie (Amiens), Clinique de l'Europe d'Amiens (Amiens), Centre Hospitalier d’Auxerre (Auxerre), Institut Sainte Catherine (Avignon) (and 34 more...)
UNICANCER
Phase 2
Breast cancer
#NCT05563220
HER2 Negative
HR Positive
Locally Advanced
Metastatic
1
2
Hormone therapy
Chemotherapy
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre de Cancérologie du Grand Montpellier (Montpellier), Centre Hospitalier Universitaire de Toulouse (Toulouse), Gustave Roussy (Villejuif), Centre Henri Becquerel (Rouen )
Stemline Therapeutics, Inc.
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05384626
Locally Advanced
Metastatic
Metastatic Castration-resistant
ALK
1
2
3 or more
AKT
ATM
BRAF
BRCA 1/2
CDK12
CHEK 1/2
ESR
FGFR
HER2
HOXB13
KRAS G12C
KRAS non G12C
MET
MSI/dMMR
NRAS
NTRK-1/2/3
PALB2
PIK3CA
PTEN
RET
Systemic Treatment-Naive
Gustave Roussy (Villejuif), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Nuvalent Inc.
Phase 2
Breast cancer
#NCT05297617
HER2 Negative
HR Positive
Localized
None
Surgery
Hormone therapy
Chemotherapy
Clinique des Cèdres - Ramsay Santé (Cornebarrieu), Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence), Clinique Chénieux (Limoges), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Hôpital NOVO (Site de Pontoise) (Pontoise) (and 42 more...)
UNICANCER
Phase 2
Breast cancer
#NCT05215106
HER2 Negative
HR Negative
Localized
None
Systemic Treatment-Naive
Surgery
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Radiotherapy
Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 2
Breast cancer
#NCT04985266
HER2 Negative
HR Positive
Localized
None
Surgery
Chemotherapy
Hormone therapy
Targeted therapy
Institut de Cancérologie et d’Hématologie Universitaire de Saint-Étienne (CHU Saint-Étienne) (Saint-Priest-en-Jarez), Institut Bergonié (Bordeaux), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Annecy Genevois (Epagny Metz-Tessy), Centre Hospitalier de Blois (Blois) (and 15 more...)
Fiducie de la Fondation Royal Marsden NHS
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Pancreas cancer
#NCT04924075
Locally Advanced
Metastatic
Other mutation
1
Systemic Treatment-Naive
Hôpital Bicêtre AP-HP (Le Kremlin-Bicêtre), Hôpital Cochin (Paris ), Hôpital de Hautepierre - Hôpitaux Universitaires de Strasbourg (Strasbourg), Gustave Roussy (Villejuif), Hôpital Edouard Herriot - Hospices Civils de Lyon (Lyon)
Merck Sharp & Dohme LLC
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
#NCT04116541
Locally Advanced
Metastatic
Metastatic Castration-resistant
ALK
BRAF
EGFR
FGFR
MET
NTRK-1/2/3
RET
ROS-1
SMAD4
Other mutation
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), IUCT Oncopôle (Toulouse), Institut Paoli-Calmettes (Marseille), Gustave Roussy (Villejuif), Centre Antoine Lacassagne (Nice) (and 2 more...)
Centre Léon Bérard